Kailera Therapeutics, Inc. (NASDAQ:KLRA) People

Kailera Therapeutics, Inc.

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Adam Koppel
Other companies: Cerevel Therapeutics Holdings Inc (Director · Oct 27, 2020 – Aug 1, 2024 · Past); Foghorn Therapeutics Inc. (Director · Oct 22, 2020 – Dec 29, 2024 · Past); BCLS Acquisition Corp (Director · Oct 21, 2020 – Oct 26, 2020 · Past); Replimune Group, Inc. (Director · Jul 24, 2018 – Jul 24, 2018 · Past); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Dicerna Pharmaceuticals Inc (Director · Apr 11, 2017 – Dec 28, 2021 · Past); Trevena, Inc. (Director · Sep 17, 2014 – May 16, 2018 · Past); Biogen Inc. (EVP, Strategy and Bus. Dev. · May 15, 2014 – Jun 6, 2016 · Past); PTC Therapeutics, Inc. (Director · Jun 19, 2013 – Jan 3, 2017 · Past)
Partner, Bain Capital Life Sciences · Since at least Apr 16, 2026
Ronald C Renaud Jr
Other companies: Upstream Bio, Inc. (Director · Since at least Oct 10, 2024); Cerevel Therapeutics Holdings Inc (President & CEO, Director · Jun 12, 2023 – Aug 1, 2024 · Past); ImageneBio, Inc. (Director · Mar 25, 2021 – Jun 9, 2022 · Past); Atara Biotherapeutics, Inc. (Director · Apr 29, 2020 – Jun 23, 2022 · Past); Translate Bio Inc (Chief Executive Officer, Director · Jun 27, 2018 – Sep 14, 2021 · Past); Chimerix Inc (Director · Dec 17, 2014 – Jun 20, 2019 · Past); Akebia Therapeutics, Inc. (Director · Sep 12, 2014 – Jun 14, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2014 – Jan 3, 2017 · Past); Idenix Pharmaceuticals Inc (President & CEO, Director · Jun 28, 2007 – Aug 5, 2014 · Past); Keryx Biopharmaceuticals Inc (Chief Financial Officer · Feb 14, 2006 – Feb 14, 2007 · Past)
CEO & President, Director · Since at least Apr 16, 2026
Martin Mackay
Other companies: SpringWorks Therapeutics Inc (Director · Since at least Jul 29, 2024); Rallybio Corporation (Co-Founder and Chairman · Since at least Jul 28, 2021); Charles River Laboratories International, Inc. (Director · Since at least Jul 1, 2017); 5 01 Acquisition Corp (Director · Oct 13, 2020 – Oct 16, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & Global Head of R&D · May 13, 2013 – Feb 27, 2017 · Past); Pfizer, Inc. (Senior Vice President · Sep 30, 2008 – May 14, 2010 · Past)
Co-Founder and Chair of Board, Rallybio Corporation · Since at least Apr 16, 2026
Frank K. Clyburn
Other companies: Cencora, Inc. (Director · Since at least Oct 1, 2024); Revolution Medicines, Inc. (Director · Since at least Aug 5, 2024); International Flavors & Fragrances, Inc. (Chief Executive Officer · Feb 14, 2022 – Mar 1, 2024 · Past); DuPont de Nemours, Inc. (Director · Jun 1, 2019 – Apr 28, 2021 · Past); Merck & Company, Inc. (EVP & Pres ? Human Health · Jan 1, 2019 – Oct 30, 2021 · Past)
Director · Since at least Apr 16, 2026
Christopher Hite
Other companies: Vera Therapeutics, Inc. (EVP and Vice Chairman, Royalty Pharma · Since at least Mar 5, 2026); Royalty Pharma plc (EVP & Chairman, Partnering · Since at least Jun 15, 2020); Acceleron Pharma Inc (Director · Jun 4, 2020 – Nov 19, 2021 · Past)
Independent Board Member · Since at least Apr 16, 2026
Doug Pagán
Other companies: Dicerna Pharmaceuticals Inc (Chief Financial Officer · May 26, 2020 – Dec 28, 2021 · Past); Alaunos Therapeutics, Inc. (Director · Sep 18, 2018 – Dec 31, 2019 · Past); Paratek Pharmaceuticals Inc (Chief Financial Officer · Dec 18, 2014 – Apr 5, 2019 · Past)
Chief Financial Officer · Since at least Apr 16, 2026
John F. Milligan
Other companies: 4D Molecular Therapeutics, Inc. (Executive Chairman · Since at least Dec 10, 2020); Pacific Biosciences of California, Inc. (Chairman of the Board · Since at least Jul 17, 2013); Gilead Sciences, Inc. (President and CEO, Director · Nov 7, 2013 – Nov 27, 2018 · Past)
Board Chair · Since at least Apr 16, 2026
Kathleen Tregoning
Other companies: COMPASS Pathways Plc (Director · Since at least May 27, 2026); Spero Therapeutics, Inc. (Director · Since at least Oct 11, 2021); Cerevel Therapeutics Holdings Inc (See Remarks · Oct 27, 2020 – Aug 1, 2024 · Past)
Chief Corporate Affairs Officer · Since at least Jun 29, 2026
Paula Cloghessy
Other companies: Seres Therapeutics, Inc. (See Remarks · Feb 7, 2022 – Oct 27, 2023 · Past); Translate Bio Inc (Chief Human Resources Officer · Jun 27, 2018 – Mar 8, 2019 · Past)
Chief People Officer · Since at least Apr 16, 2026
Paul Burgess
Other companies: Cerevel Therapeutics Holdings Inc (See Remarks · Jun 20, 2023 – Aug 1, 2024 · Past); Translate Bio Inc (General Counsel and Secretary · Jun 27, 2018 – Jun 27, 2018 · Past)
Chief Operating Officer & Chief Business Officer · Since at least Apr 16, 2026
Andrew Kaplan
Other companies: Surgery Partners, Inc. (Director · Aug 31, 2018 – Dec 19, 2023 · Past)
Partner, Bain Capital Private Equity · Since at least Apr 16, 2026
Nur Nicholson
Other companies: Apellis Pharmaceuticals, Inc. (Chief Technical Officer · Since at least Sep 25, 2020)
Chief Technology Officer · Since at least Aug 11, 2026
Scott Akamine
Other companies: Cerevel Therapeutics Holdings Inc (Chief Legal Officer · May 24, 2021 – Aug 1, 2024 · Past)
Chief Legal Officer · Since at least Apr 16, 2026
Anna RobinsonVice President, Communications · Since at least Nov 3, 2026
Jamie ColemanChief Commercial Officer · Since at least Apr 16, 2026
Maura GavaghanVice President, Investor Relations · Since at least Nov 3, 2026
Ron RenaudPresident & Chief Executive Officer · Since at least Jun 11, 2026
Scott WassermanChief Medical Officer · Since at least Apr 16, 2026
Yuting LiuDirector · Since at least Apr 16, 2026